Patent: 10,851,118
✉ Email this page to a colleague
Summary for Patent: 10,851,118
Title: | Compositions and methods for inhibiting arginase activity |
Abstract: | The invention relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the invention. Also provided herein are methods of treating cancer with the arginase inhibitors of the invention. |
Inventor(s): | Sjogren Eric B., Li Jim, Van Zandt Michael, Whitehouse Darren |
Assignee: | CALITHERA BIOSCIENCES, INC. |
Application Number: | US16101275 |
Patent Claims: | see list of patent claims |
Details for Patent 10,851,118
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | January 10, 1978 | ⤷ Subscribe | 2038-08-10 |
Amgen Inc. | NEUPOGEN | filgrastim | Injection | 103353 | February 20, 1991 | ⤷ Subscribe | 2038-08-10 |
Amgen Inc. | NEUPOGEN | filgrastim | Injection | 103353 | June 28, 2000 | ⤷ Subscribe | 2038-08-10 |
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | May 07, 2001 | ⤷ Subscribe | 2038-08-10 |
Genzyme Corporation | LEMTRADA | alemtuzumab | Injection | 103948 | November 14, 2014 | ⤷ Subscribe | 2038-08-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |